两种检测男性生殖道沙眼衣原体和解脲支原体方法的对比

doi:10.19723/j.issn.1671-167X.2021.04.027

摘要/Abstract

摘要：

目的: 对比应用实时荧光核酸恒温扩增(simultaneous amplification and testing,SAT)-RNA(SAT-RNA 法)与应用聚合酶链式反应(polymerase chain reaction,PCR)-DNA(PCR-DNA法)检测男性生殖道沙眼衣原体、解脲支原体的效果,以探讨SAT-RNA法的应用价值。方法: 收集2016年4月至2017年4月于中国医科大学附属盛京医院生殖医学中心就诊的因女方因素拟行体外受精-胚胎移植助孕的163例男性,采用SAT-RNA法检测尿液标本中的沙眼衣原体、解脲支原体,并对其中109例符合当天采集精液标本条件者进行相应病原体的检测。同时采用PCR-DNA法检测163例男性尿道拭子标本中的相应病原体。结果: 163例男性生殖道解脲支原体检测结果表明,PCR-DNA法尿道拭子检测阳性77例(阳性率47.24%),SAT-RNA法尿液标本检测阳性78例(阳性率47.85%),两者差异无统计学意义(χ² =0,P>0.05),两种方法的检测结果符合率为93.25%,阳性符合率93.51%,阴性符合率93.02%,检验结果一致性极好(Kappa值0.865)。163例男性生殖道沙眼衣原体检测结果表明,PCR-DNA法尿道拭子检测阳性5例(阳性率3.07%),SAT-RNA法尿液标本检测阳性7例(阳性率4.29%),两者差异无统计学意义(χ²=0.25,P>0.05),两种方法检测结果符合率为97.55%,阳性符合率80.00%,阴性符合率98.10%,检验结果一致性较好(Kappa值0.654)。对其中109例男性采用SAT-RNA法同时检测尿液和精液标本中的解脲支原体和沙眼衣原体:(1)解脲支原体:尿液标本阳性55例(阳性率50.46%),精液标本阳性49例(阳性率44.95%),两标本差异无统计学意义(χ²=2.08,P>0.05),检测结果符合率为88.99%,阳性符合率93.88%,阴性符合率85.00%,检验结果一致性较好(Kappa值0.780);(2)沙眼衣原体:尿液标本阳性6例(阳性率5.50%),精液标本阳性4例(阳性率3.67%),两标本差异无统计学意义(χ²=0.5,P>0.05),检测结果符合率为98.17%,阳性符合率100.00%,阴性符合率98.10%,检验结果一致性较好(Kappa值0.791)。结论: SAT-RNA法与PCR-DNA法检测生殖道沙眼衣原体、解脲支原体有良好的一致性;相比PCR-DNA法,SAT-RNA法可用于尿液或精液标本的检测,具有无创、方便等优势,更适宜临床应用。

关键词: 生殖道感染, 沙眼衣原体, 解脲支原体, 男性, 实时荧光核酸恒温扩增

Abstract:

Objective: To investigate the value of clinical application of simultaneous amplification and testing of RNA (SAT-RNA) for detecting Chlamydia trachomatis (CT) and Ureaplasma urealyticum (UU) by comparing with the polymerase chain reaction testing of DNA (PCR-DNA) method. Methods: Specimens from both urethra swab and the first avoid urine which should be at least one hour after the previous urination were collected from 163 men who were scheduled for in vitro fertilization and embryo transfer (IVF-ET) treatment due to female factors at Center for Reproductive Medicine, Shengjing Hospital of China Medical University during the period of April 2016 to April 2017. Among the 163 men, 109 simultaneously provided semen that was collected after 3-7 days of sexual abstinence for the testing. Urine and semen specimens were detected for CT and UU with SAT-RNA, while urethra swab specimens were detected for CT and UU with standard PCR-DNA. Detection results of the SAT-RNA were compared with those of the PCR-DNA method. Results: The positive rate of UU in the urethra swab detected with PCR-DNA and that of UU in the urine with SAT-RNA were 47.24% and 47.85%, respectively, and the coincidence rate was 93.25%. In addition, the positive and negative coincidence rates were 93.51% and 93.02%, respectively, and the concordance between the two methods was very good (Kappa=0.865). On the other hand, the positive rate of CT in the swab specimen tested with PCR-DNA was 3.07% and that of CT in urine with SAT-RNA was 4.29%, and the coincidence rate was 97.55%. Moreover, the positive and negative coincidence rates were 80.00% and 98.10%, respectively, and the concordance between the two methods was good (Kappa=0.654). Regarding SAT-RNA detection of UU in the urine and semen specimen of the 109 patients, the positive rates of UU in the urine and semen specimens were 50.46% and 44.95%, respectively; and the coincidence rate between the two specimens was 88.99%. In addition, the positive coincidence rate and the negative coincidence rate was 93.88% and 85.00%, respectively, and the concordance between the two specimens was good (Kappa=0.780). Similarly, SAT-RNA detection of CT in the urine and semen specimens showed the positive rate was 5.50% and 3.67%, respectively; and the two specimens showed 98.17% coincidence rate. The positive and negative coincidence rates were 100.00% and 98.10%, respectively, and the concordance was also good (Kappa=0.791). Conclusion: SAT-RNA detection of CT and UU in the urine specimen showed good concordance with the PCR-DNA detection of CT and UU in the urethra swab specimen. In addition, the concordance was also good between the urine and semen specimens detected with SAT-RNA. These results indicate that, as a less invasive and equally accurate procedure, SAT-RNA may be more suitable for clinical application.

Key words: Reproductive tract infections, Chlamydia trachomatis, Ureaplasma urealyticum, Male, Simultaneous amplification and testing

中图分类号:

R691.3

杜强,洪锴,潘伯臣. 两种检测男性生殖道沙眼衣原体和解脲支原体方法的对比[J]. 北京大学学报（医学版）, 2021, 53(4): 785-788.

DU Qiang,HONG Kai,PAN Bo-chen. Comparison of two methods for detection of Chlamydia trachomatis and Ureaplasma urealyticum in male reproductive tract[J]. Journal of Peking University (Health Sciences), 2021, 53(4): 785-788.

图/表 4

表1

表2

表3

表4

参考文献 20

[1]	Moi H, Blee K, Horner PJ. Management of non-gonococcal urethritis [J]. BMC Infect Dis, 2015, 15:294. doi: 10.1186/s12879-015-1043-4
[2]	《非淋菌性尿道炎病原学诊断专家共识》编写组, 商学军. 非淋菌性尿道炎病原学诊断专家共识 [J]. 中华男科学杂志, 2016, 22(11):1038-1043.
[3]	骆振刚, 李瑞鹏, 王彦彬, 等. 实时荧光核酸恒温扩增技术检测泌尿生殖道生殖支原体感染临床观察 [J]. 中华男科学杂志, 2019, 25(6):535-538.
[4]	中华医学会. 临床诊疗指南辅助生殖技术与精子库分册[M]. 北京: 人民卫生出版社, 2019.
[5]	Davies MJ, Rumbold AR, Marino JL, et al. Maternal factors and the risk of birth defects after IVF and ICSI: A whole of population cohort study [J]. BJOG, 2017, 124(10):1537-1544. doi: 10.1111/bjo.2017.124.issue-10
[6]	王千秋, 刘全忠, 徐金华. 梅毒、淋病、生殖器疱疹、生殖道沙眼衣原体感染诊疗指南(2014) [J]. 中华皮肤科杂志, 2014, 47(5):365-372.
[7]	李婧, 岳晓丽, 张家晖, 等. 全球生殖道沙眼衣原体感染的流行状况 [J]. 国际流行病学传染病学杂志, 2020, 47(5):419-422.
[8]	韦剑洪, 方小武, 张旭宾, 等. 沙眼衣原体感染对不育男性精子质量的影响 [J]. 中华疾病控制杂志, 2012, 16(8):724-725.
[9]	Huang C, Long X, Jing S, et al. Ureaplasma urealyticum and Mycoplasma hominis infections and semen quality in 19 098 infertile men in China [J]. World J Urol, 2016, 34(7):1039-1044. doi: 10.1007/s00345-015-1724-z
[10]	Zhang L, Zhang KP, Liang CZ. Ureaplasma urealyticum in male genital tract: A hidden risk factor for male infertility [J]. Andrologia, 2016, 48(10):1077-1079. doi: 10.1111/and.12577 pmid: 27897333
[11]	郑渠, 刘玮, 张国巍, 等. RNA恒温扩增法与培养法检测解脲脲原体结果比较分析 [J]. 中华男科学杂志, 2017, 23(8):717-721.
[12]	王彦彬, 诸靖宇, 李瑞鹏, 等. 实时荧光核酸恒温扩增技术在泌尿生殖道解脲脲原体感染中的应用 [J]. 中华医院感染学杂志, 2016, 26(23):5322-5324.
[13]	韩燕, 陈凯, 朱邦勇, 等. 实时荧光核酸恒温扩增技术检测无创样本沙眼衣原体的性能 [J]. 国际流行病学传染病学杂志, 2020, 47(5):402-405.
[14]	张岱, 刘朝晖. 生殖道支原体感染诊治专家共识 [J]. 中国性科学, 2016, 25(3):80-82.
[15]	孙颖浩. 吴阶平泌尿外科学[M]. 北京: 人民卫生出版社, 2019.
[16]	顾伟鸣, 杨阳, 吴磊, 等. 实时荧光核酸恒温扩增技术检测泌尿生殖道沙眼衣原体感染 [J]. 临床检验杂志, 2010, 28(4):271-272.
[17]	骆振刚, 李瑞鹏, 王彦彬, 等. 实时荧光核酸恒温扩增技术检测泌尿生殖道生殖支原体感染临床观察 [J]. 中华男科学杂志, 2019, 25(6):535-538.
[18]	冯强, 马志伟, 王寓, 等. 男性不育症患者生殖支原体感染与精液常规参数及精子DNA完整性的相关性 [J]. 中华男科学杂志, 2020, 26(10):900-905.
[19]	李维娜, 朱文兵, 刘刚. 生殖支原体感染与男性不育相关性分析 [J]. 中华男科学杂志, 2018, 24(11):999-1004.
[20]	宣岩, 魏兰馨, 洪翔, 等. 我国不同人群生殖支原体感染率的Meta分析 [J]. 中华流行病学杂志, 2021, 42(2):335-342.

相关文章 14

[1]	李远骋, 崔闻心, 郭雪儿, 朱璠, 刘思辰, 贾碧波, 汪培, 马迎华. 青年学生男男性行为人群中人类免疫缺陷病毒阳性与阴性者获得性免疫缺陷综合征(艾滋病)相关知识与行为比较[J]. 北京大学学报（医学版）, 2021, 53(3): 511-517.
[2]	王涛,许克新,张维宇,胡浩,张晓威,王焕瑞,刘献辉,陈京文,张晓鹏. 男性膀胱过度活动症的尿动力学分型及临床疗效随访[J]. 北京大学学报（医学版）, 2019, 51(6): 1048-1051.
[3]	代晓微，徐影，郑连文，李凌云，李丹丹，谭鑫，高飞，王艳，吴桂杰. 1 324例少精子症和无精子症患者的染色体核型分析[J]. 北京大学学报(医学版), 2018, 50(5): 774-777.
[4]	吴桂杰，马帅，郑连文，徐影，孟繁鹤，代晓微. 1例复杂染色体易位伴男性不育患者的家系核型分析及文献复习[J]. 北京大学学报(医学版), 2018, 50(4): 729-731.
[5]	赵连明，姜辉，洪锴，林浩成，唐文豪，刘德风，毛加明，廉颖，马潞林. Y染色体AZFc区缺失患者的治疗结局分析[J]. 北京大学学报(医学版), 2016, 48(4): 607-611.
[6]	叶海云，许清泉，黄晓波，马凯，王晓峰. 卡介苗膀胱灌注治疗致结核性前列腺脓肿1例[J]. 北京大学学报(医学版), 2015, 47(6): 1039-1041.
[7]	姚林, 张雷, 范宇, 张政, 徐燕鹏, 刘茗洁, 何志嵩, 龚侃, 李学松, 张争, 张崔健, 周利群. 前瞻随机对照研究：新技术对硬性膀胱镜患者舒适度的提高[J]. 北京大学学报（医学版）, 2014, 46(4): 635-637.
[8]	陈亮, 付杰, 陈菲, 潘虹, 张娜, 王玲, 王晟, 鞠慧岩, 薛晴, 贺占举, 左文莉, 徐阳, 杨慧霞. Y染色体长度变异对男性生育功能的影响[J]. 北京大学学报（医学版）, 2014, 46(2): 211-214.
[9]	许克新, 张晓鹏, 王栋, 胡浩, 黄晓波, 王晓峰. AdVance经闭孔吊带治疗男性中、重度压力性尿失禁的疗效[J]. 北京大学学报（医学版）, 2012, 44(4): 555-557.
[10]	杨槐, 刘俊, 张利朝, 何恢绪, 胡卫列, 吕军, 张小明, 吴实坚. 保留尿道板纵切卷管尿道成形术后并发症原因分析与防治探讨[J]. 北京大学学报（医学版）, 2012, 44(4): 551-554.
[11]	黄锦, 廉颖, 乔杰, 刘平. 男性罗氏易位的临床特点及其胚胎着床前遗传学诊断[J]. 北京大学学报（医学版）, 2012, 44(4): 544-546.
[12]	姜辉, 田杨, 黄锦, 赵连明, 唐文豪, 洪锴, 毛加明. 重视染色体基因缺陷对男性生育的影响[J]. 北京大学学报（医学版）, 2012, 44(4): 504-506.
[13]	涂响安, 赵良运, 赵亮, 王文卫, 邓立文, 陈羽, 邓春华. 经尿道射精管切开术治疗射精管梗阻的效果(附60例报告)[J]. 北京大学学报（医学版）, 2011, 43(4): 559-561.
[14]	方鹏骞, 徐娟, 张佳慧, 李翠, 杨芳, 孔鹏, 孙杨. 艾滋病高危人群规模间接估计方法的应用及其结果的外推研究[J]. 北京大学学报（医学版）, 2008, 40(2): 214-218.

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed

Urine (SAT-RNA)	Urethral swab (PCR-DNA)		Total
Urine (SAT-RNA)	+	-	Total
+	4	3	7
-	1	155	156
Total	5	158	163

Urine (SAT-RNA)	Semen (SAT-RNA)		Total
Urine (SAT-RNA)	+	-	Total
+	4	2	6
-	0	103	103
Total	4	105	109